Comparing Januvia vs Lantus
Januvia | Lantus |
|
---|
Januvia (sitagliptin) | Lantus (insulin glargine) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Januvia is a DDP-4 inhibitor that is used in addition to other medications for the treatment of type 2 diabetes. Rarely, it may cause joint pain, skin reactions, pancreatitis, or an allergic... View more |
Prescription only
Lantus is a long-acting insulin that only needs to be injected once a day, subcutaneously. It is available as a prefilled pen (Lantus Solostar) or a 10mL vial. Hypoglycemia is the most common side... View more |
Related suggestions Diabetes, Type 2
|
|||||||
More about Januvia (sitagliptin) | More about Lantus (insulin glargine) | ||||||||
Ratings & Reviews | |||||||||
Januvia has an average rating of 4.7 out of 10 from a total of 137 ratings on Drugs.com. 31% of reviewers reported a positive effect, while 50% reported a negative effect. |
Lantus has an average rating of 6.5 out of 10 from a total of 41 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 29% reported a negative effect. |
||||||||
Drug Class | |||||||||
Side Effects | |||||||||
See also: Januvia side effects in more detail. |
See also: Lantus side effects in more detail. |
||||||||
Generic Availability | |||||||||
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Lantus prices |
||||||||
Dosage Forms Available | |||||||||
|
|
||||||||
Brand Names | |||||||||
Other sitagliptin brands include: Zituvio | Other insulin glargine brands include: Basaglar, Lantus SoloStar, Rezvoglar, Semglee, Toujeo Max SoloStar, Toujeo SoloStar | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||
12.4 hours |
24 hours |
||||||||
CSA Schedule ** View glossary of terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 287 drugs are known to interact with Januvia:
|
A total of 385 drugs are known to interact with Lantus:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
October 16, 2006 |
April 20, 2000 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.